Bumper Offer - Urjas oil Just @ Rs. 1
Zolax 0.25 Tablet, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Anxiety. Zolax 0.25 Tablet also has some secondary and off-label uses. These are listed below.
The correct dosage of Zolax 0.25 Tablet depends on the patient's age, gender, and medical history. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
Some other side effects of Zolax 0.25 Tablet have been listed ahead. Such side effects of Zolax 0.25 Tablet normally do not last long and go away once the treatment is completed. However, if these continue for a longer time, consult your doctor right away.
In addition, Zolax 0.25 Tablet's effect is Severe during pregnancy and Severe for lactating mothers. Further, the section on Zolax 0.25 Tablet related warnings talks about Zolax 0.25 Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Glaucoma, Epilepsy, Myasthenia Gravis (MG) must refrain from the use of Zolax 0.25 Tablet since this can cause severe adverse effects. Other contraindications of Zolax 0.25 Tablet have been discussed in the sections ahead.
Drug interactions for Zolax 0.25 Tablet have been reported in the medical literature. A complete list of these interactions is given below.
In addition to these precautions, you may also note that Zolax 0.25 Tablet is not safe while driving, and is is not addictive in nature.
Zolax 0.25 Tablet is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
Is the use of Zolax 0.25 Tablet safe for pregnant women?
Pregnant women may get severe side effects after taking Zolax. If you are pregnant, do not take Zolax without a doctor's advice.
Is the use of Zolax 0.25 Tablet safe during breastfeeding?
Taking Zolax may lead to serious side effects if you are breastfeeding. Zolax should not be taken by breastfeeding women unless prescribed by the doctor.
What is the effect of Zolax 0.25 Tablet on the Kidneys?
Zolax rarely affects the kidneys.
What is the effect of Zolax 0.25 Tablet on the Liver?
Zolax may have severe effects on your liver, so do not take it without first consulting your doctor.
What is the effect of Zolax 0.25 Tablet on the Heart?
Side effects of Zolax rarely affect the heart.
Zolax 0.25 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Zolax 0.25 Tablet unless your doctor advises you to do so -
Is this Zolax 0.25 Tablet habit forming or addictive?
Yes, Zolax 0.25 Tablet can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Zolax 0.25 Tablet you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but take Zolax 0.25 Tablet only as per medical advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Zolax 0.25 Tablet can help with mental disorders.
Interaction between Food and Zolax 0.25 Tablet
When consumed with certain foods, Zolax 0.25 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Zolax 0.25 Tablet
Taking Zolax 0.25 Tablet and alcohol together may cause some problems. If you notice any of these side effects, it is best to go to your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; XANAX® alprazolam
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 405
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 129-131